相关实验视频

Updated: Jul 28, 2025

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

奎尔素对Aβ42二次体的抑制作用和分子机制:一个分子动力学模拟研究

Mei Fang¹, Xin Wang¹, Kehe Su¹

¹Department of Chemistry, School of Chemistry and Chemical Engineering, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.

|May 30, 2023

概括

奎尔素通过阻碍形状变化,有效地抑制了粉样β (Aβ) 二元聚合. 这项研究揭示了奎尔塞丁的存在.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
计算生物学计算生物学

背景情况:

粉样β (Aβ) 二聚体是关键的神经毒性寡聚体,与阿尔茨海默病有关.
抑制Aβ二元聚合对于早期阿尔茨海默病的干预至关重要.
已知奎尔素会影响Aβ纤维素的形成,但其对二元体的机制尚不清楚.

研究的目的:

调查奎尔素在抑制Aβ(1-42) 双元形状变化的分子机制.
通过分子动力学模拟,探索奎尔素对Aβ(1-42) 二次体的早期抑制作用.
为了确定奎尔氨酸度对Aβ二聚体-奎尔氨酸相互作用的影响.

主要方法:

使用丰富的线圈结构构建一个Aβ(1-42) 二元模型.
所有原子分子动力学模拟的Aβ ((1-42) 二次体与氨酸在1:5和1:10的摩尔比.
分子相互作用和结合亲缘关系的分析.

主要成果:

奎尔丁分子成功地阻碍了Aβ(1-42) 二次体的构造变化.
观察到Aβ1-42二聚体和奎尔塞丁之间有更强的相互作用和结合亲和力,其摩尔比为1:10与1:5相比.
奎尔丁的抑制作用依赖于度.

结论:

奎尔丁显示出作为Aβ(1-42) 双元形状转换的抑制剂的潜力.
这些发现提供了对氏素抗聚合效应背后的分子机制的见解.
这项研究可能有助于开发针对阿尔茨海默病中Aβ二分体聚合的新疗法.

更多相关视频

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

相关概念视频

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...